For millions of Americans, the pharmacy counter has become a place of profound anxiety. What should be a routine stop for health maintenance often transforms into a stressful calculation of trade-offs, where the cost of a life-saving pill is weighed against other basic necessities like groceries or rent.
This tension is reflected in a growing trend of prescription drug affordability concerns. According to data from KFF, nearly six in ten adults (59%) now report being worried about their ability to afford medications for themselves or their family members. This represents a steady climb in public anxiety since 2018, suggesting that for many, the financial burden of healthcare is not just a static challenge, but one that is becoming more acute.
As a physician, I witness the clinical fallout of these numbers every day. When a patient cannot afford their medication, they don’t simply stop their treatment; they often attempt to “manage” it in ways that are medically dangerous. This gap between a doctor’s prescription and a patient’s ability to pay is creating a public health crisis of nonadherence that transcends income brackets, though it hits the most vulnerable the hardest.
The ‘Polypharmacy’ Penalty
The struggle to afford medication is not distributed evenly. There is a clear correlation between the number of prescriptions a person requires—a state often referred to as polypharmacy—and their financial strain. While roughly 65% of adults overall find it relatively easy to afford their medications, that confidence evaporates for those with complex health needs.
Nearly four in ten adults (37%) who take four or more prescription drugs report difficulty affording their medicine, compared to just 18% of those taking three or fewer. For these patients, the cumulative cost of multiple prescriptions creates a “compounding effect” that can quickly overwhelm a monthly budget.
The anxiety is pervasive even among those not currently taking medication. Approximately 57% of adults who do not leverage prescriptions express worry about future costs, reflecting a broader systemic fear that a single diagnosis could lead to financial instability.
Socioeconomic Gaps in Healthcare Access
While affordability is a general concern, the “very worried” category reveals deep systemic inequities. The burden falls most heavily on those without a safety net or those living in households with an annual income of less than $40,000, where 27% of adults describe themselves as very worried about costs.
Race and insurance status further complicate the landscape. Substantial shares of uninsured adults under 65 (32%), Hispanic adults (30%), and Black adults (26%) report being very worried about their ability to pay for medications. This suggests that the current pricing structures and insurance gaps are disproportionately impacting marginalized communities.
The Role of Federal Safety Nets
Federal programs like Medicare and Medicaid provide essential buffers, but they are not absolute shields. About 19% of Medicare enrollees remain very worried about costs. However, recent policy shifts through the Inflation Reduction Act of 2022 have begun to improve coverage for those in Medicare Part D plans by capping out-of-pocket spending.
For those on Medicaid, the situation is more nuanced. While the program limits out-of-pocket costs to nominal amounts, roughly 24% of Medicaid enrollees under 65 are still very worried about affordability. For a family living in extreme poverty, even a nominal co-pay can be prohibitive, leading to delayed care or skipped doses.
| Demographic Group | Percentage “Very Worried” |
|---|---|
| Uninsured Adults (<65) | 32% |
| Hispanic Adults | 30% |
| Black Adults | 26% |
| Household Income <$40k | 27% |
| Medicare Enrollees | 19% |
The Hidden Danger: Cost-Related Rationing
The most alarming aspect of prescription drug affordability is not the worry itself, but the behavioral changes it triggers. When patients cannot afford their medicine, they engage in “rationing”—a practice that can lead to disease progression, emergency room visits, and avoidable deaths.
About 43% of adults report that they have not taken their medication as prescribed in the past year due to cost. This is not a monolithic behavior; patients employ several different, and often risky, strategies to stretch their supply:
- Substitution: 31% opted for an over-the-counter drug instead of the prescribed medication.
- Avoidance: 27% simply did not fill the prescription.
- Rationing: 19% cut pills in half or skipped doses entirely.
Among those with annual household incomes under $40,000, this rate of nonadherence jumps to 52%. From a medical perspective, cutting a pill in half without a score line or skipping doses of a maintenance drug (such as an antihypertensive or insulin) can result in unpredictable drug serum levels and catastrophic health failures.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a healthcare provider before changing how you take your medications.
The trajectory of prescription drug costs remains a focal point of federal policy. The next critical checkpoint will be the continued rollout of the Inflation Reduction Act’s drug price negotiation provisions, which aim to lower the cost of some of the most expensive medications for Medicare beneficiaries. Whether these systemic changes can trickle down to the uninsured and those on Medicaid remains a primary concern for public health advocates.
Do you or a loved one struggle with medication costs? Share your experience in the comments or share this article to help others find resources for affordable care.
